Banner Image

Test Directory

HIV-1 Genotype (RTI, PI, Integrase Inhibitors)

Order Code: HIVING

Test Summary

Identify drug resistance mutations in HIV-1 patients failing antiretroviral regimens containing RT, PR or Integrase inhibitors.
Identify transmitted drug resistance mutations in the RT, PR or integrase genes in treatment-naive patients prior to initiation of antiretroviral therapy.

Aliases

  • N/A

Specimen Collection

Order Code

HIVING

EPIC (Premier) Code

LAB6186

Includes

HIV-1 Integrase Genotype
HIV-1 Genotype

CPT Code

  • 87900
  • 87901
  • 87906

Billing Code

  • 671013
  • 670002
  • 670001

CPT Statement

Methodology

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) • Sequencing

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Department

Reference Testing

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Monday - Saturday; Report available: 4 - 9 days

Specimen Collection

Billing

CPT Code

  • 87900
  • 87901
  • 87906

Billing Code

  • 671013
  • 670002
  • 670001

CPT Statement

Result Information

Methodology

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) • Sequencing

Testing Laboratory

N/A

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Monday - Saturday; Report available: 4 - 9 days